| scholarly article | Q13442814 |
| P50 | author | Robert A Bonomo | Q62516257 |
| Travis B Nielsen | Q91989803 | ||
| P2093 | author name string | Brad Spellberg | |
| Paul Pantapalangkoor | |||
| Darren Wong | |||
| Brian Luna | |||
| P2860 | cites work | Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis | Q24201201 |
| Bacteremia caused by Acinetobacter ursingii | Q24550977 | ||
| Signature motifs identify an Acinetobacter Cif virulence factor with epoxide hydrolase activity | Q24568297 | ||
| Reservoirs of Non-baumannii Acinetobacter Species | Q26766441 | ||
| Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond | Q26771783 | ||
| Acinetobacter infection--an emerging threat to human health | Q26861494 | ||
| Combination therapies for combating antimicrobial resistance | Q27015710 | ||
| Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration | Q27339544 | ||
| Microbial synergy via an ethanol-triggered pathway | Q27938765 | ||
| Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections | Q28084708 | ||
| Acinetobacter in modern warfare | Q28263145 | ||
| Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii | Q36035894 | ||
| Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection. | Q36052630 | ||
| Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection. | Q36053482 | ||
| Global challenge of multidrug-resistant Acinetobacter baumannii | Q36095081 | ||
| Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. | Q36099594 | ||
| Excess deaths associated with tigecycline after approval based on noninferiority trials | Q36115632 | ||
| Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal | Q36150941 | ||
| Combination therapy for treatment of infections with gram-negative bacteria | Q36156077 | ||
| Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013 | Q36246604 | ||
| Clinical impact and pathogenicity of Acinetobacter. | Q36282248 | ||
| Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice | Q36314004 | ||
| Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii. | Q36318967 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Infrequent air contamination with Acinetobacter baumannii of air surrounding known colonized or infected patients | Q36390792 | ||
| Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis | Q36457770 | ||
| Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods | Q36547397 | ||
| Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia | Q36559388 | ||
| Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes | Q36569183 | ||
| Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness | Q36575078 | ||
| Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? | Q36611906 | ||
| Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept | Q36633627 | ||
| The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit | Q36633704 | ||
| The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. | Q36646787 | ||
| Acinetobacter seifertii Isolated from China: Genomic Sequence and Molecular Epidemiology Analyses. | Q36664024 | ||
| Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. | Q36746061 | ||
| Trauma-related infections in battlefield casualties from Iraq | Q36800879 | ||
| Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology | Q36804312 | ||
| The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner | Q36849931 | ||
| White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens | Q36854025 | ||
| Intraspecies Transfer of the Chromosomal Acinetobacter baumannii blaNDM-1 Carbapenemase Gene | Q36887836 | ||
| Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii. | Q36887978 | ||
| Community-acquired Acinetobacter infections | Q36911392 | ||
| Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis | Q36913254 | ||
| Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity | Q46581461 | ||
| Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India | Q46742865 | ||
| Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii | Q46939760 | ||
| Distribution of the blaOXA-23-containing transposons Tn2006 and Tn2008 in Australian carbapenem-resistant Acinetobacter baumannii isolates | Q47938576 | ||
| Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin | Q48040631 | ||
| Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii | Q48048984 | ||
| Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility | Q49138790 | ||
| Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). | Q50940090 | ||
| Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. | Q51379524 | ||
| Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. | Q51554133 | ||
| Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. | Q51733097 | ||
| K19 capsular polysaccharide of Acinetobacter baumannii is produced via a Wzy polymerase encoded in a small genomic island rather than the KL19 capsule gene cluster. | Q53078312 | ||
| Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. | Q53121080 | ||
| CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation. | Q53530929 | ||
| Structure of repeating unit of the capsular polysaccharide from Acinetobacter baumannii D78 and assignment of the K4 gene cluster. | Q53973487 | ||
| Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. | Q54083016 | ||
| IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan. | Q54303551 | ||
| Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. | Q54351983 | ||
| High endemic levels of multidrug-resistant Acinetobacter baumannii among hospitals in southern Brazil. | Q54357839 | ||
| A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. | Q54384104 | ||
| Building a benchmark through active surveillance of intensive care unit-acquired infections: the Italian network SPIN-UTI | Q59447730 | ||
| Differential Roles of CD14 and Toll-like Receptors 4and 2 in MurineAcinetobacterPneumonia | Q62516238 | ||
| The Acute‐Phase Response and Serum Amyloid A Inhibit the Inflammatory Response toAcinetobacter baumanniiPneumonia | Q62516241 | ||
| Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System | Q64131324 | ||
| Acinetobacter species: which do we mean? | Q67571571 | ||
| Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance | Q67708324 | ||
| Infections due to organisms of the genus Herellea. B5W and B. anitratum | Q76473847 | ||
| The United States Food and Drug Administration and the end of antibiotics | Q77440626 | ||
| Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia | Q34162588 | ||
| Stress response and virulence functions of the Acinetobacter baumannii NfuA Fe-S scaffold protein | Q34216622 | ||
| Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii | Q34228361 | ||
| Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources | Q34288902 | ||
| Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection | Q34328536 | ||
| A fatal case of multidrug resistant acinetobacter necrotizing fasciitis: the changing scary face of nosocomial infection | Q34366502 | ||
| Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. | Q34368824 | ||
| Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii | Q34483646 | ||
| Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa | Q34555131 | ||
| Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. | Q34574281 | ||
| An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. | Q34579696 | ||
| Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, | Q34597608 | ||
| Two cases of necrotizing fasciitis due to Acinetobacter baumannii | Q34598764 | ||
| Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection | Q34653632 | ||
| Gram-negative infections in adult intensive care units of latin america and the Caribbean | Q34695842 | ||
| A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii. | Q34726120 | ||
| Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. | Q34764355 | ||
| Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78 | Q34779353 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| Causes of infection after earthquake, China, 2008. | Q34908091 | ||
| Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico | Q35005198 | ||
| Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene | Q35032793 | ||
| Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis | Q35101242 | ||
| Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii | Q35101682 | ||
| Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem | Q35132306 | ||
| Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors | Q35134033 | ||
| Acinetobacter baumannii RecA protein in repair of DNA damage, antimicrobial resistance, general stress response, and virulence | Q35139132 | ||
| Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance | Q35139329 | ||
| Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model | Q35168859 | ||
| Dissemination of blaOXA-23 in Acinetobacter spp. in China: main roles of conjugative plasmid pAZJ221 and transposon Tn2009 | Q35168950 | ||
| In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii | Q35169078 | ||
| Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii | Q35187576 | ||
| Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics | Q35202480 | ||
| Do antibiotic combinations prevent the emergence of resistant organisms? | Q39527576 | ||
| Effect of desiccation on the ultrastructural appearances of Acinetobacter baumannii and Acinetobacter lwoffii | Q39603231 | ||
| The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes | Q39786245 | ||
| Survival of Acinetobacter baumannii on dry surfaces | Q40013606 | ||
| Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. | Q40087259 | ||
| Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement | Q40252535 | ||
| A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii | Q40434847 | ||
| Studies on Pneumococcus Variation: I. Variants Characterized by Rapid Lysis and Absence of Normal Growth under the Routine Method of Cultivation. | Q40574376 | ||
| Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy. | Q40611400 | ||
| Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis | Q40612894 | ||
| Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance | Q40646501 | ||
| Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro | Q40655676 | ||
| Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013). | Q40700100 | ||
| OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections | Q40700556 | ||
| Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation | Q40732203 | ||
| The first cases of human bacteremia caused by Acinetobacter seifertii in Japan | Q40829471 | ||
| Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia | Q40854491 | ||
| Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases | Q40883429 | ||
| Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb | Q40892025 | ||
| Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies | Q40892705 | ||
| Geographical patterns in antimicrobial resistance of acinetobacter in clinical isolates | Q40933983 | ||
| Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study | Q41008459 | ||
| Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro | Q41031269 | ||
| Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection | Q41050257 | ||
| Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii. | Q41089013 | ||
| Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study | Q41092223 | ||
| Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. | Q41138033 | ||
| Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. | Q41348499 | ||
| Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii | Q41364861 | ||
| Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study | Q41403170 | ||
| Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses | Q41427005 | ||
| Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii | Q41448443 | ||
| Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. | Q41524681 | ||
| A 4-year prospective study to determine the incidence and microbial etiology of surgical site infections at a private tertiary care hospital in Mumbai, India | Q41560142 | ||
| Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. | Q41561999 | ||
| Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis. | Q41623346 | ||
| Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats | Q41654959 | ||
| Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain | Q41668012 | ||
| Bad bugs need old drugs: a stewardship program's evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections | Q41676559 | ||
| Genetic Manipulation of Acinetobacter baumannii | Q41678791 | ||
| Antibiotic resistance and phylogenetic characterization of Acinetobacter baumannii strains isolated from commercial raw meat in Switzerland | Q41680011 | ||
| Pathogenicity of clinical Acinetobacter baumannii isolates in a Galleria mellonella host model according to bla(OXA-40) gene and epidemiological outbreak status | Q41907650 | ||
| Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain | Q41918992 | ||
| Patterns of nosocomial infections, multidrug-resistant microorganisms, and mold detection after extensive black-water flooding: a survey from central Thailand | Q41968461 | ||
| Microbiologic characteristics of pathogenic bacteria from hospitalized trauma patients who survived Wenchuan earthquake | Q41974103 | ||
| Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. | Q41998459 | ||
| Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors | Q41998725 | ||
| Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation | Q42014835 | ||
| The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects | Q42025143 | ||
| Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics | Q42025783 | ||
| Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany | Q42037228 | ||
| Hospital-acquired infections following the 1999 Marmara earthquake | Q42041112 | ||
| Antibacterial activities of iron chelators against common nosocomial pathogens | Q42075825 | ||
| CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. | Q42100476 | ||
| AbuO, a TolC-like outer membrane protein of Acinetobacter baumannii, is involved in antimicrobial and oxidative stress resistance | Q42132845 | ||
| Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals | Q42167294 | ||
| Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals | Q42221541 | ||
| Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. | Q42228164 | ||
| Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients | Q42234026 | ||
| Prevalence of carbapenem-hydrolyzing class D β-lactamase genes in Acinetobacter spp. isolates in China. | Q42234875 | ||
| Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes | Q42245284 | ||
| The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor | Q42428390 | ||
| The deadly impact of extreme drug resistance in Acinetobacter baumannii | Q42575612 | ||
| Bacteriology of war wounds at the time of injury | Q42600453 | ||
| Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials | Q42643577 | ||
| The Response of Acinetobacter baumannii to Zinc Starvation. | Q42735239 | ||
| Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India | Q42758854 | ||
| A difficult case of necrotizing fasciitis caused by Acinetobacter baumannii | Q42785229 | ||
| Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis | Q28274696 | ||
| Fatal case of multi-drug resistant Acinetobacter baumannii necrotizing fasciitis | Q28286321 | ||
| Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii | Q28392232 | ||
| Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection | Q28478751 | ||
| The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence | Q28483237 | ||
| Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation | Q28484155 | ||
| Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection | Q28504978 | ||
| Differential Role of the T6SS in Acinetobacter baumannii Virulence | Q28548409 | ||
| Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients | Q28550492 | ||
| Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence | Q28552441 | ||
| Alternatives to antibiotics—a pipeline portfolio review | Q29365161 | ||
| Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins | Q30160281 | ||
| Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens | Q30499245 | ||
| Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program | Q30559669 | ||
| Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. | Q30580647 | ||
| Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii. | Q30761262 | ||
| Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens | Q30882972 | ||
| Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. | Q31031386 | ||
| Identification of an OprD homologue in Acinetobacter baumannii | Q33228855 | ||
| Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis | Q33535645 | ||
| Vaccines for Acinetobacter baumannii: thinking "out of the box". | Q33637895 | ||
| The battle for iron between bacterial pathogens and their vertebrate hosts | Q33658687 | ||
| Detection of KPC in Acinetobacter spp. in Puerto Rico | Q33676198 | ||
| AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments. | Q33709547 | ||
| Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung | Q33724918 | ||
| Nutritional immunity beyond iron: a role for manganese and zinc. | Q33761982 | ||
| Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii | Q33798301 | ||
| Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker | Q33820538 | ||
| Transferrin iron starvation therapy for lethal bacterial and fungal infections | Q33883214 | ||
| Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur | Q33899575 | ||
| Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex | Q34058025 | ||
| Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey | Q34058739 | ||
| Community-acquired Acinetobacter meningitis in adults | Q34119206 | ||
| Diversity within the O-linked protein glycosylation systems of acinetobacter species | Q34157681 | ||
| Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells | Q36913299 | ||
| Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a | Q36920951 | ||
| Mutations Decreasing Intrinsic β-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii | Q36933374 | ||
| Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. | Q36949518 | ||
| H-NS plays a role in expression of Acinetobacter baumannii virulence features. | Q36970729 | ||
| IncM Plasmid R1215 Is the Source of Chromosomally Located Regions Containing Multiple Antibiotic Resistance Genes in the Globally Disseminated Acinetobacter baumannii GC1 and GC2 Clones. | Q36986499 | ||
| A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain | Q37036579 | ||
| Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice | Q37099423 | ||
| In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357. | Q37122285 | ||
| Functional features of TonB energy transduction systems of Acinetobacter baumannii | Q37123826 | ||
| Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. | Q37124050 | ||
| Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options | Q37150308 | ||
| Rapid determination of quinolone resistance in Acinetobacter spp. | Q37191622 | ||
| Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. | Q37213637 | ||
| GES-11, a novel integron-associated GES variant in Acinetobacter baumannii | Q37274713 | ||
| Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections. | Q37287693 | ||
| Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. | Q37338009 | ||
| Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii | Q37364565 | ||
| A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline | Q37374012 | ||
| The contribution of nutrient metal acquisition and metabolism to Acinetobacter baumannii survival within the host | Q37385154 | ||
| Health-care associated infections rates, length of stay, and bacterial resistance in an intensive care unit of Morocco: findings of the International Nosocomial Infection Control Consortium (INICC). | Q37395537 | ||
| Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible Acinetobacter baumannii. | Q37418760 | ||
| Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in bangalore, India | Q37429651 | ||
| Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. | Q37544333 | ||
| In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem. | Q37544741 | ||
| Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria | Q37544860 | ||
| Validation of a novel murine wound model of Acinetobacter baumannii infection | Q37643643 | ||
| Hospital acquired infections among patients admitted in the medical and surgical wards of a non-teaching secondary care hospital in northern India. | Q37679110 | ||
| Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection | Q37680545 | ||
| Insights into acinetobacter war-wound infections, biofilms, and control | Q37714265 | ||
| Treatment of Acinetobacter infections. | Q37760952 | ||
| Confronting multidrug-resistant Acinetobacter baumannii: a review | Q37815829 | ||
| Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies | Q37996299 | ||
| Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models | Q38008459 | ||
| Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis | Q38052888 | ||
| Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. | Q38057841 | ||
| Emerging therapies for multidrug resistant Acinetobacter baumannii | Q38073927 | ||
| Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems | Q38126768 | ||
| Community-acquired necrotizing fasciitis caused by Acinetobacter calcoaceticus: a case report and literature review | Q38186236 | ||
| Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review | Q38212031 | ||
| Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. | Q38243475 | ||
| A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections | Q38265153 | ||
| A GC1 Acinetobacter baumannii isolate carrying AbaR3 and the aminoglycoside resistance transposon TnaphA6 in a conjugative plasmid. | Q38294708 | ||
| Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania | Q38365121 | ||
| Genetic tools for manipulating Acinetobacter baumannii genome: an overview | Q38463382 | ||
| High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia | Q38470424 | ||
| Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins | Q38491423 | ||
| In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam | Q38495174 | ||
| Combined therapy for multi-drug-resistant Acinetobacter baumannii infection--is there evidence outside the laboratory? | Q38556441 | ||
| Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene. | Q38692948 | ||
| Characterization of surface antigen protein 1 (SurA1) from Acinetobacter baumannii and its role in virulence and fitness | Q38782983 | ||
| Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure | Q38873222 | ||
| Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups | Q38876666 | ||
| Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia | Q38902086 | ||
| The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells | Q38962879 | ||
| KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst. | Q39017163 | ||
| Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii | Q39116650 | ||
| The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. | Q39186713 | ||
| New Delhi metallo-β-lactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes | Q39297102 | ||
| Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia | Q39300668 | ||
| The value of single-pathogen antibacterial agents. | Q39309271 | ||
| Diversity of Acinetobacter baumannii strains isolated in humans, companion animals, and the environment in Reunion Island: an exploratory study. | Q39333801 | ||
| Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans | Q39342649 | ||
| Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria | Q39385974 | ||
| In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. | Q39442834 | ||
| Surveillance for and susceptibility of Acinetobacter baumannii in a large hospital and burn center in Shanghai, China, 2007-2013. | Q39470106 | ||
| Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients. | Q39472836 | ||
| Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia | Q42905606 | ||
| "Airborne assault": a new dimension in Acinetobacter baumannii transmission*. | Q42924406 | ||
| Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia | Q42930254 | ||
| Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration | Q43014198 | ||
| Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time? | Q43202091 | ||
| Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed | Q43226964 | ||
| Global spread of carbapenem-resistant Acinetobacter baumannii | Q43227337 | ||
| Diabetic murine models for Acinetobacter baumannii infection | Q43237805 | ||
| Epidemiology and impact of imipenem resistance in Acinetobacter baumannii | Q43254058 | ||
| Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). | Q43260620 | ||
| The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4. | Q43463983 | ||
| Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). | Q43473623 | ||
| A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii | Q43499545 | ||
| Influence of iron on growth, production of siderophore compounds, membrane proteins, and lipase activity in Acinetobacter calcoaceticus BD 413. | Q43571316 | ||
| A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia | Q43574348 | ||
| Osteomyelitis in military personnel wounded in Iraq and Afghanistan | Q43635993 | ||
| Some immunological properties of lipopolysaccharide from Acinetobacter baumannii | Q43790242 | ||
| Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials | Q44023944 | ||
| Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study | Q44043080 | ||
| pACICU2 is a conjugative plasmid of Acinetobacter carrying the aminoglycoside resistance transposon TnaphA6. | Q44095392 | ||
| Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii | Q44342508 | ||
| Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe | Q44551413 | ||
| Infections in combat casualties during Operations Iraqi and Enduring Freedom | Q44718619 | ||
| Distribution of Acinetobacter species on skin of healthy humans | Q44759996 | ||
| International study of the prevalence and outcomes of infection in intensive care units | Q44988294 | ||
| Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii | Q45051391 | ||
| The siderophore-mediated iron acquisition systems of Acinetobacter baumannii ATCC 19606 and Vibrio anguillarum 775 are structurally and functionally related | Q45140773 | ||
| Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State | Q45399885 | ||
| Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation | Q45580188 | ||
| Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. | Q45974680 | ||
| Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii. | Q45992218 | ||
| Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series | Q46177552 | ||
| Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. | Q35270405 | ||
| Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. | Q35530666 | ||
| Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance | Q35551122 | ||
| Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii | Q35595613 | ||
| Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia | Q35661920 | ||
| Fitness cost of antibiotic susceptibility during bacterial infection | Q35707529 | ||
| Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study | Q35764830 | ||
| Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D. | Q35778670 | ||
| A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. | Q35794129 | ||
| Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice | Q35805487 | ||
| Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies | Q35829780 | ||
| Host-Microbe Protein Interactions during Bacterial Infection | Q35835388 | ||
| Multidrug-resistant Acinetobacter extremity infections in soldiers | Q35873386 | ||
| Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs | Q35874041 | ||
| Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis | Q35888304 | ||
| Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem | Q35914401 | ||
| Genetic analysis of surface motility in Acinetobacter baumannii | Q35959825 | ||
| Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA | Q36008636 | ||
| Acinetobacter skin colonization of US Army Soldiers | Q79811618 | ||
| Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance | Q83368782 | ||
| Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia | Q83473464 | ||
| Gram-negative osteomyelitis: clinical and microbiological profile | Q83494833 | ||
| Acinetobacter infections in a tertiary level intensive care unit in northern India: epidemiology, clinical profiles and outcomes | Q84026157 | ||
| High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils | Q84159892 | ||
| Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study | Q84516666 | ||
| Aerosolized Colistin for the Treatment of Multidrug-resistant Acinetobacter baumannii Pneumonia: Experience in a Tertiary Care Hospital in Northern Taiwan | Q84675360 | ||
| Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like | Q84974548 | ||
| Multidrug-resistant Acinetobacter baumannii causing necrotizing fasciitis in a pancreas-kidney transplant recipient: a case report | Q85007190 | ||
| Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study | Q85096838 | ||
| Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii | Q85911482 | ||
| Clinical implications of glycoproteomics for Acinetobacter baumannii | Q86247890 | ||
| Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections | Q86533675 | ||
| Aerosolization of Acinetobacter baumannii in a trauma ICU* | Q86976740 | ||
| Acinetobacter baumannii K27 and K44 capsular polysaccharides have the same K unit but different structures due to the presence of distinct wzy genes in otherwise closely related K gene clusters | Q86985305 | ||
| High prevalence of closely-related Acinetobacter baumannii in pets according to a multicentre study in veterinary clinics, Reunion Island | Q87419028 | ||
| Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China | Q87430368 | ||
| A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia | Q88082413 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathophysiology | Q1135939 |
| Acinetobacter infectious disease | Q18975322 | ||
| P304 | page(s) | 409-447 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges | |
| P478 | volume | 30 |
| Q111348957 | 16S rDNA metabarcoding of the bacterial community associated with workers of Pheidole rugaticeps Emery (Hymenoptera: Formicidae) |
| Q89848731 | A Fatal Case of Septic Shock Secondary to Acinetobacter Bacteremia Acquired from a Platelet Transfusion |
| Q61805238 | A Porcine Wound Model of Infection |
| Q52647607 | A canine urinary tract infection representing the first clinical veterinary isolation of Acinetobacter ursingii. |
| Q54949802 | A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. |
| Q95271559 | Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece |
| Q64888257 | Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012. |
| Q42694349 | Acinetobacter baumannii Virulence Traits: A Comparative Study of a Novel Sequence Type with Other Italian Endemic International Clones |
| Q58723207 | Acinetobacter baumannii maintains its virulence after long-time starvation |
| Q93166792 | Acinetobacter junii as a rare pathogen of urinary tract infection |
| Q58803761 | Acinetobacter spp. porin Omp33-36: Classification and transcriptional response to carbapenems and host cells |
| Q52646120 | Acinetobacter: an emerging pathogen with a versatile secretome. |
| Q90658005 | Acquisition of plasmids conferring carbapenem and aminoglycoside resistance and loss of surface-exposed macromolecule structures as strategies for the adaptation of Acinetobacter baumannii CC104O/CC15P strains to the clinical setting |
| Q90134720 | Adenovirus infection is associated with altered gut microbial communities in a non-human primate |
| Q64963647 | Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine. |
| Q48102108 | An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds |
| Q90526068 | Analysis of by high-throughput sequencing: Helicobacter pylori infection and salivary microbiome |
| Q60921107 | Analysis of colony phase variation switch in Acinetobacter baumannii clinical isolates |
| Q90748612 | Analysis of the Extracellular Proteome of Colistin-Resistant Korean Acinetobacter baumannii Strains |
| Q46273551 | Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy |
| Q33732524 | Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections |
| Q64089857 | Antimicrobial Susceptibility of Complex and Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016) |
| Q92000710 | Antimicrobial resistance in nephrology |
| Q90304013 | Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii |
| Q47729013 | Changes in mouse gut bacterial community in response to different types of drinking water |
| Q90403590 | Characteristics of the urinary microbiome in kidney stone patients with hypertension |
| Q89965170 | Characterization of Acinetobacter baumannii Copper Resistance Reveals a Role in Virulence |
| Q93026404 | Characterization of a small plasmid carrying the carbapenem resistance gene bla OXA-72 from community-acquired Acinetobacter baumannii sequence type 880 in China |
| Q99712213 | Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant Acinetobacter baumannii |
| Q97518312 | Chromosome Architecture and Gene Content of the Emergent Pathogen Acinetobacter haemolyticus |
| Q89982235 | Co-occurrence of plasmid-mediated tigecycline and carbapenem resistance in Acinetobacter spp. from waterfowls and their neighboring environment |
| Q90647663 | Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections |
| Q89861973 | Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients |
| Q47562492 | Combating carbapenem-resistant Acinetobacter baumannii by an optimized imipenem plus tobramycin dosage regimen - prospective validation via hollow fiber infection and mathematical modeling |
| Q91832701 | Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients |
| Q89924406 | Community-acquired in name only: A cluster of carbapenem-resistant Acinetobacter baumannii in a burn intensive care unit and beyond |
| Q97521171 | Comparative Genomics of Acinetobacter baumannii Clinical Strains From Brazil Reveals Polyclonal Dissemination and Selective Exchange of Mobile Genetic Elements Associated With Resistance Genes |
| Q53700898 | Comparison of septic shock due to MDR Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in ICU patients. |
| Q92511000 | Composition and Dynamics of Bacterial Communities in a Full-Scale Mineral Water Treatment Plant |
| Q93048532 | Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II |
| Q60301194 | CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII |
| Q55091723 | Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints. |
| Q57281753 | Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR |
| Q55486832 | Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study. |
| Q94525921 | Discovery of a Novel Hypervirulent Acinetobacter baumannii Strain in a Case of Community-Acquired Pneumonia |
| Q54207272 | Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates. |
| Q64880146 | Diversity of metallo-β-lactamase-encoding genes found in distinct species of Acinetobacter isolated from the Brazilian Amazon Region. |
| Q92935128 | Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria |
| Q49886862 | Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria |
| Q93197815 | Genomic and Phenotypic Analyses of Acinetobacter baumannii Isolates From Three Tertiary Care Hospitals in Thailand |
| Q38926189 | GigA and GigB are Master Regulators of Antibiotic Resistance, Stress Responses, and Virulence in Acinetobacter baumannii. |
| Q97074353 | Green Synthesis of AuNPs by Acinetobacter sp. GWRVA25: Optimization, Characterization, and Its Antioxidant Activity |
| Q47652694 | High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates |
| Q92404410 | Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion |
| Q91386510 | Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress |
| Q99237565 | Identification of a Novel Acinetobacter baumannii Phage-Derived Depolymerase and Its Therapeutic Application in Mice |
| Q92764918 | Identification of a Novel Plasmid Carrying mcr-4.3 in an Acinetobacter baumannii Strain in China |
| Q57817509 | Identification of the Ribonuclease P Catalytic Subunit: Cleavage of a Target mRNA in the Presence of an External Guide Sequence |
| Q33774463 | Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii |
| Q92707811 | In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program |
| Q60923787 | In vitro activity of colistin in combination with various antimicrobials against species, a report from South Iran |
| Q64912756 | In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. |
| Q92256765 | Influence of Sampling Site and other Environmental Factors on the Bacterial Community Composition of Domestic Washing Machines |
| Q47706889 | Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors. |
| Q90362523 | Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen |
| Q47136007 | Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii |
| Q92946552 | K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis |
| Q94561407 | Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme |
| Q98202475 | Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment |
| Q92875295 | Mobilizable antibiotic resistance genes are present in dust microbial communities |
| Q43563522 | Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis |
| Q64111471 | Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia |
| Q89068708 | Multidrug-Resistant Acinetobacter baumannii Chloramphenicol Resistance Requires an Inner Membrane Permease |
| Q90402314 | Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations |
| Q90236842 | Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia |
| Q91989820 | Natural history of Acinetobacter baumannii infection in mice |
| Q92033212 | New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors |
| Q57461276 | New Treatment Options Against Carbapenem-Resistant Infections |
| Q50020762 | New shuttle vectors for gene cloning and expression in multidrug-resistant Acinetobacter species. |
| Q57800928 | OXA-23, a prevalent mechanism contributing to sulbactam resistance in diverse clinical strains |
| Q57294459 | OxyR regulates the transcriptional response to hydrogen peroxide |
| Q50185124 | Pathogenic Bacterium Acinetobacter baumannii Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion |
| Q92024039 | Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis |
| Q91899277 | Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects |
| Q57789772 | Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects |
| Q52598182 | Postoperative infection caused by Acinetobacter baumannii misdiagnosed as a free-living amoeba species in a humeral head hemiarthroplasty patient: a case report. |
| Q92576300 | Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection |
| Q91877872 | Prevalence and antibiotic resistance of Acinetobacter baumannii among patients in postcardiac surgery intensive care units of Rajaei Hospital, Tehran |
| Q64120082 | Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire |
| Q64966545 | Rapid detection and molecular survey of blaVIM, blaIMP and blaNDM genes among clinical isolates of Acinetobacter baumannii using new multiplex real-time PCR and melting curve analysis. |
| Q60951089 | Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by |
| Q92117942 | Resistome and a Novel blaNDM-1-Harboring Plasmid of an Acinetobacter haemolyticus Strain from a Children's Hospital in Puebla, Mexico |
| Q57293300 | Role of capsule in resistance to disinfectants, host antimicrobials and desiccation in |
| Q47103050 | SPR741, an Antibiotic Adjuvant, Potentiates the In Vitro and In Vivo Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii |
| Q92718164 | Sepsis Attributed to Bacterial Contamination of Platelets Associated with a Potential Common Source - Multiple States, 2018 |
| Q61806012 | Signal Transduction Proteins in : Role in Antibiotic Resistance, Virulence, and Potential as Drug Targets |
| Q49743186 | Site-Specific Recombination at XerC/D Sites Mediates the Formation and Resolution of Plasmid Co-integrates Carrying a blaOXA-58- and TnaphA6-Resistance Module in Acinetobacter baumannii |
| Q90013012 | Small Molecule Potentiation of Gram-Positive Selective Antibiotics against Acinetobacter baumannii |
| Q90597870 | Spatiotemporal dynamics of multidrug resistant bacteria on intensive care unit surfaces |
| Q104611955 | Spread of tet(X5) and tet(X6) genes in multidrug-resistant Acinetobacter baumannii strains of animal origin |
| Q46308613 | Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors |
| Q47744180 | The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies |
| Q64079715 | The Capsule Depolymerase Dpo48 Rescues and Mice From Systemic Infections |
| Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
| Q47406932 | The frequency and mechanism of spontaneous resistance to sulbactam combined with the novel β-lactamase inhibitor ETX2514 in clinical isolates of Acinetobacter baumannii. |
| Q59125140 | The lytic transglycosylase MltB connects membrane homeostasis and in vivo fitness of Acinetobacter baumannii |
| Q47661746 | Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy |
| Q94545399 | Transcriptome Profiling of Lung Innate Immune Responses Potentially Associated With the Pathogenesis of Acinetobacter baumannii Acute Lethal Pneumonia |
| Q96813799 | Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii |
| Q46237978 | Uncovering the mechanisms of Acinetobacter baumannii virulence |
| Q96231653 | Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA |
| Q89824042 | Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response |
Search more.